Following BRAF mutation, the second most common mutation observed in thyroid cancer are the mutations of RAS proto-oncogenes, which play an important role in the initiation of thyreocyte neoplastic transformation[12,55,56]. Here, BRAF is linked to thyroid gland carcinoma.